Medivir AB (SE0020181014) — research page
SE · se-cm-kg/XSTO/SE0020181014 · as of 2026-11-06
Identity and listing
The issuer is Medivir AB, listed on Nasdaq Stockholm under ticker SE0020181014, with ISIN SE0020181014 and LEI 549300VWDGUX0WMJ1T79. Security type, segment, sector and jurisdiction are not on the record. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Medivir AB | source · 2026-11-06 |
| exchange | Nasdaq Stockholm | source · 2026-11-06 |
| ticker | SE0020181014 | source · 2026-11-06 |
| ISIN | SE0020181014 | source · 2026-11-06 |
| LEI | 549300VWDGUX0WMJ1T79 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 43 filings across 40 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 7 days. The latest filing is an Interim report (Q1 and Q3) dated 2026-11-05, 1 day before the record date of 2026-11-06. The exchange median for filings is 30.0, against 43 for the issuer. The exchange median cadence gap is 9.5 days, and the exchange median latency is 7.0 days. The sector peer figures are not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 43 | 7 | 1 |
| exchange median: Nasdaq Stockholm (398 issuers) | 30 | 9.5 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | Interim report (Q1 and Q3) | Interim report (Q1 and Q3) | MEDIVIR AB - INTERIM REPORT JANUARY - SEPTEMBER 2026 |
| 2026-09-30 | Total number of voting rights and capital | Total number of voting rights and capital | Number of shares and votes in Medivir AB on September 30, 2026 |
| 2026-08-20 | Half Year financial report | Half Year financial report | MEDIVIR AB - INTERIM REPORT JANUARY - JUNE 2026 |
| 2026-07-31 | Total number of voting rights and capital | Total number of voting rights and capital | Number of shares and votes in Medivir AB after Directed Share Issue |
| 2026-07-20 | Decisions of general meeting | Decisions of general meeting | Bulletin from the Extraordinary General Meeting in Medivir AB (publ) |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted.
Orderability
The outcome is not determinable because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 3 research houses: Carnegie, Redeye and Maxim Group LLC.
| research house | analyst | source · read date |
|---|---|---|
| Carnegie | Klas Palin | issuer page · 2026-11-12 |
| Redeye | Richard Ramanius | issuer page · 2026-11-12 |
| Maxim Group LLC | Jason McCarthy | issuer page · 2026-11-12 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/XSTO/SE0020181014 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://www.medivir.com/investors/stock-information (coverage)
- 10.7
- https://mcp.se-cm-kg.ai/record/XSTO/SE0020181014 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0020181014"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:9b9bdc7c702c9503.